Abstract:Chagas disease predominantly affects the heart, esophagus, and colon in its chronic phase. However, the precise infection mechanisms of the causal agent Trypanosoma cruzi in these tissue types remain incompletely understood. This study investigated T . cruzi infection dynamics in skeletal (SM) and cardiac myotubes (CM) differentiated from H9c2(2–1) myoblasts (control). SM and CM were generated using 1% fetal bovine serum (FBS) without or with retinoic acid, respectively. Initial invasion efficiencies and numbers of released parasites were equivalent between undifferentiated and differentiated cells (~0.3–0.6%). Concomitantly, parasite motility patterns were similar across cell lines. However, CM demonstrated significantly higher infection kinetics over time, reaching 13.26% infected cells versus 3.12% for SM and 3.70% for myoblasts at later stages. Cellular automata modeling suggested an enhanced role for cell-to-cell transmission in driving the heightened parasitism observed in CM. The increased late-stage susceptibility of CM, potentially mediated by cell-to-cell transfer mechanisms of the parasite, aligns with reported clinical tropism patterns. The myotube infection models provide novel insights into Chagas disease pathogenesis that are not fully attainable through in vivo examination alone. Expanding knowledge in this area could aid therapeutic development for this neglected illness. Trypanosoma cruzi is a parasite that causes Chagas disease. While most initial infections are cleared by the immune system, some people develop a chronic infection that can emerge decades later and damage the heart or digestive system. This study aimed to understand why the heart is preferentially affected. We studied the infection dynamics of T . cruzi in different muscle cell models cultured in vitro: myoblast cells, and cardiac muscle-like or skeletal muscle-like cells differentiated from myoblasts. All three cell types were equally susceptible to initial parasite invasion. However, at later times, the cardiac muscle cell model displayed higher overall infection levels compared to the other cell types. Examining intracellular and released parasites over time revealed that cardiac cells harbored more parasites at later infection stages, despite similar parasite release across models. This ruled out shedding as the cause of disparate infection levels. Mathematical modeling suggested that higher rates of cell-to-cell transmission drive elevated late-stage infection in the cardiac model. Comparing infection kinetics between models provides insights into heart susceptibility to chronic damage from T . cruzi in vivo. Understanding disease mechanisms could aid prevention and treatment strategies for this important health issue.

Congenital transmission of Chagas disease: The role of newborn therapy on the disease's dynamics

Congenital transmission of Chagas disease: The role of newborn therapy on the disease’s dynamics

Trypanosoma cruzi Infection at the Maternal-Fetal Interface: Implications of Parasite Load in the Congenital Transmission and Challenges in the Diagnosis of Infected Newborns

Estimation of the morbidity and mortality of congenital Chagas disease: A systematic review and meta-analysis

Preventing Vertical Transmission of Chagas Disease: An Emerging Public Health Issue in Perinatal Care

Prevention of congenital chagas disease by trypanocide treatment in women of reproductive age: A meta-analysis of observational studies

From serological surveys to disease burden: a modelling pipeline for Chagas disease

Challenges and advancements in the development of vaccines and therapies against Chagas disease

Parasitic Effects on the Congenital Transmission of Trypanosoma cruzi in Mother–Newborn Pairs

Tackling the Challenges of human Chagas Disease: a Comprehensive Review of Treatment Strategies in the Chronic Phase and Emerging Therapeutic Approaches

Preventing the Transmission of American Trypanosomiasis and Its Spread into Non-Endemic Countries

Efficacy of short-course treatment for prevention of congenital transmission of Chagas disease: A retrospective cohort study

Metacyclogenesis as the Starting Point of Chagas Disease

What are the translational challenges associated with Chagas disease drug discovery?

In vitro characterization of Trypanosoma cruzi infection dynamics in skeletal and cardiac myotubes models suggests a potential cell-to-cell transmission in mediating cardiac pathology

Alternative Approaches for the Treatment of Chagas Disease

The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis

The End Justifies the Means: Chagas Disease from a Perspective of the Host–Trypanosoma cruzi Interaction

Challenges in Chagas Disease Drug Development

Treatments and the Perspectives of Developing a Vaccine for Chagas Disease

Treatment options for Chagas Disease: a systematic review and meta-analysis applied to the preclinical studies using animal models